Filter Results :

Your search for Biotech and Diagnostics returned 12 reports

Sort by


Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015

01 Jul 2015  |  Published by:  CurrentPartnering
The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies. This second edition, includes: -Trends...

$ 1,995.00

Read More

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

01 Jun 2015  |  Published by:  CurrentPartnering
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how ...

$ 2,995.00

Read More

Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015

01 Jun 2015  |  Published by:  CurrentPartnering
The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2005-2015 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides deta...

$ 2,995.00

Read More

Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2015

01 May 2015  |  Published by:  CurrentPartnering
The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed under...

$ 2,995.00

Read More

Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

05 Feb 2015  |  Published by:  CurrentPartnering
The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies. The report provides a detailed understand and analysis of...

$ 3,495.00

Read More

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

05 Feb 2015  |  Published by:  CurrentPartnering
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revis...

$ 1,995.00

Read More

Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

05 Feb 2015  |  Published by:  CurrentPartnering
The Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed understan...

$ 3,495.00

Read More

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Dec 2014  |  Published by:  CurrentPartnering
 The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies. The report provides a detailed ...

$ 3,295.00

Read More

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Dec 2014  |  Published by:  CurrentPartnering
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. -Comprehensive directory of royalty financing deals since 2007 -Royalty financing contract documents -Roy...

$ 1,995.00

Read More

Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Nov 2014  |  Published by:  CurrentPartnering
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provides a ...

$ 2,995.00

Read More

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

26 Sep 2014  |  Published by:  MarketsandMarkets
Report Description The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing ...

$ 4,650.00

Read More

Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Apr 2014  |  Published by:  CurrentPartnering
The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and anal...

$ 2,995.00

Read More
Total 12 records.